Published 19 days ago

It's the first drug shown to slow Alzheimer's. Why is is it off to a slow start?

Summary by Ground News

The first drug shown to slow Alzheimer’s disease hit the U.S. market over a year ago, but sales have lagged, major hospital systems have taken months to start using it and some insurers have rejected coverage.Doctors also expect some patients will hesitate to take Leqembi due to its limited impact and potential side effects. They say it will take years to learn how best to deploy the drug and that work must be done to improve diagnosis. More than 6 million Americans, and millions more worldwide, have Alzheimer’s disease, the most common cause of dementia. There’s no cure, but Leqembi clears a sticky brain protein called amyloid that’s a key indicator of Alzheimer’s. Studies showed that it can delay the progression of the disease by a few months when given to people with mild symptoms. Some experts say the delay may be too subtle for patients to notice.

0 Articles

All

Left

Center

Right

Associated Press News

It's the first drug shown to slow Alzheimer's. Why is is it off to a slow start?

The first drug shown to slow Alzheimer’s hit the U.S. market over a year ago, but sales have lagged and diagnosis and treatment remain complicated. Major hospital systems have taken

19 days ago·United States

Read Full Article

abc News

It's the first drug shown to slow Alzheimer's. Why is is it off to a slow start?

The first drug shown to slow Alzheimer’s hit the U.S. market over a year ago, but sales have lagged and diagnosis and treatment remain complicated

20 days ago·United States

Read Full Article

The Washington Post

It's the first drug shown to slow Alzheimer's. Why is is it off to a slow start?

The first drug shown to slow Alzheimer’s hit the U.S. market over a year ago, but sales have lagged and diagnosis and treatment remain complicated

19 days ago

Read Full Article

KRDO

It's the first drug shown to slow Alzheimer's. Why is is it off to a slow start?

By TOM MURPHY AP Health Writer The first drug shown to slow Alzheimer’s disease hit the U.S. market over a year ago, but sales have lagged, major hospital systems have taken months to start using it and some insurers have rejected coverage. Doctors also expect some patients will hesitate to take Leqembi due to its limited impact and potential side effects. They say it will take years to learn how best to deploy the drug and that work must be don…

19 days ago·Colorado Springs, United States

Read Full Article

KVIA

It's the first drug shown to slow Alzheimer's. Why is is it off to a slow start?

19 days ago·Panama City, United States

Read Full Article

Winnipeg Free Press

It's the first drug shown to slow Alzheimer's. Why is is it off to a slow start?

The first drug shown to slow Alzheimer’s disease hit the U.S. market over a year ago, but sales have lagged, major hospital systems have taken months to start using it […]

19 days ago·Winnipeg, Canada

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Coverage Details

Total News Sources0

Leaning Left10Leaning Right1Center8Last Updated19 days agoBias Distribution

53% Left

Bias Distribution

53% of the sources lean Left

53% Left

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

It's the first drug shown to slow Alzheimer's. Why is is it off to a slow start?

0 Articles

0 Articles

It's the first drug shown to slow Alzheimer's. Why is is it off to a slow start?

It's the first drug shown to slow Alzheimer's. Why is is it off to a slow start?

It's the first drug shown to slow Alzheimer's. Why is is it off to a slow start?

It's the first drug shown to slow Alzheimer's. Why is is it off to a slow start?

It's the first drug shown to slow Alzheimer's. Why is is it off to a slow start?

It's the first drug shown to slow Alzheimer's. Why is is it off to a slow start?

It's the first drug shown to slow Alzheimer's. Why is is it off to a slow start?

It's the first drug shown to slow Alzheimer's. Why is is it off to a slow start?

It's the first drug shown to slow Alzheimer's. Why is is it off to a slow start?

It's the first drug shown to slow Alzheimer's. Why is is it off to a slow start?

It's the first drug shown to slow Alzheimer's. Why is is it off to a slow start?

It's the first drug shown to slow Alzheimer's. Why is is it off to a slow start?

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics